Stanley Zimba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Stanley Zimba | Clinical Neuroscience | Best Researcher Award

Dr. Stanley Zimba | University of Zambia School of Medicine | Zambia

Stanley Zimba is a distinguished neurologist and academic whose career reflects a rare blend of clinical excellence, research innovation, and medical leadership. With a strong educational foundation in medicine and advanced training in neurology, he has dedicated himself to improving neurological care and education in Zambia. His professional endeavors span across clinical practice in leading hospitals, teaching roles at multiple universities, and leadership in professional organizations. His research has focused on neuroHIV, neuromuscular disorders, and epilepsy, often conducted in collaboration with globally recognized institutions. His outstanding work has earned him prestigious international fellowships, awards, and recognition, making him a prominent voice in neurology within sub-Saharan Africa.

Profile

Orcid

Early Academic Pursuits

Stanley Zimba began his academic journey with a strong foundation in the sciences, excelling early in his studies and securing recognition as one of the most outstanding students of his time. His pursuit of higher education led him to the University of Zambia, where he undertook rigorous training in medicine. He first completed a degree in Human Biology before advancing to obtain his Bachelor of Medicine and Bachelor of Surgery. His intellectual curiosity and commitment to medical excellence propelled him to further specialization with a Master of Medicine in Internal Medicine. Driven by a passion for advancing neurological sciences, he embarked on advanced fellowship training in Adult Neurology and later pursued doctoral research in Adult Neurology at the University of Zambia, building the foundation for his career as a clinician–scientist.

Professional Endeavors

Zimba’s professional career has been deeply rooted in both clinical practice and academic medicine. As a consultant neurologist, he has played a central role in establishing neurology services within Zambia’s leading medical institutions, including the University Teaching Hospital where he leads the Neurology and Hematology Unit. His expertise has been sought by private hospitals, where he contributes to expanding access to specialized neurological care. Beyond hospital practice, his influence extends into academia, where he serves as an honorary lecturer across several medical universities in Zambia, shaping the next generation of physicians. His leadership extends further into professional organizations, where he has assumed prominent roles that guide the direction of neurological practice and training within the country.

Contributions and Research Focus

At the heart of Zimba’s career lies a dedication to advancing knowledge in neurology, with particular attention to neurological complications of infectious diseases, neuroHIV, neuromuscular disorders, and epilepsy. His research activities have been strengthened through international collaborations with institutions such as Johns Hopkins University, Harvard University, and the University of Cape Town. He has engaged in translational research exploring the interface between infectious diseases and neurological health, addressing critical gaps in understanding how conditions such as HIV contribute to neurological morbidity. His academic work reflects a blend of clinical expertise and research innovation, positioning him as a leading figure in developing evidence-based approaches to neurological care in sub-Saharan Africa.

Accolades and Recognition

Zimba’s academic and professional journey has been marked by significant recognition from both local and international institutions. He has received prestigious scholarships and fellowships from globally renowned organizations, including the American Academy of Neurology, the Fogarty International Center, and the Peripheral Nerve Society. His contributions have also been acknowledged through competitive awards for scholarly excellence, such as recognition for best scientific presentations and leadership fellowships in global health research. These honors reflect not only his personal commitment to academic excellence but also the international value of his work in neurology.

Impact and Influence

Through his roles in clinical practice, teaching, and leadership, Zimba has had a profound impact on the development of neurology in Zambia. As head of neurology services in the nation’s largest teaching hospital, he has shaped clinical protocols and advanced the training of physicians in specialized neurological care. His academic mentorship has inspired many young medical professionals to pursue careers in neurology and internal medicine. His leadership in professional associations has also created platforms for collaboration, advocacy, and policy development, ensuring that neurological health remains a priority in national and regional health agendas.

Legacy in Medical Leadership

Zimba’s leadership extends beyond the clinic and classroom into national medical governance. By directing specialist training programs and contributing to the regulation of internal medicine through the Health Professions Council of Zambia, he has influenced the standards of medical education and practice across the country. His presidency of the Neurological Association of Zambia positions him as a central figure in shaping the future of neurological practice, advocacy, and awareness, ensuring that patients with neurological disorders receive improved recognition and care.

Future Contributions

Looking forward, Zimba is poised to leave a lasting legacy through his continued commitment to advancing neurological sciences in Zambia and the wider region. His doctoral research and international collaborations promise to generate new insights into neurological disease management, while his leadership roles will likely foster stronger systems for specialist training and healthcare delivery. By combining clinical expertise, academic mentorship, and institutional leadership, he is set to play an instrumental role in positioning Zambia as a center of excellence for neurology in Africa. His career trajectory illustrates a deep dedication not only to scientific advancement but also to the betterment of patient care and health systems in resource-limited settings.

Publications

The Association of Premature Atherosclerosis with Ischemic Stroke in Young People with HIV in Lusaka, Zambia
Authors: Stanley Zimba; Owen Ngalamika; Emmanuel Mukambo; Theresa Shankanga; Bwalya Mulenga; Mike Chisha; Violet Kayamba; Lloyd Mulenga; Omar Siddiqi; Owen A. Ross et al.
Year: 2025

Clinical Reasoning: Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load
Authors: Lorraine Chishimba Chishimba; Mashina Chomba; Stanley Zimba; Melody Tunsubilege Asukile; Obrie Makai; Deanna R. Saylor
Year: 2023

The case of a 42‐year‐old man with progressive gait instability, dysarthria, and dysphagia
Authors: Jennifer Adrissi; Mashina Chomba; Lorraine Chishimba; Stanley Zimba; Igor J. Koralnik; Deanna Saylor
Year: 2023

A Notable Prevalence of HIV-Associated Stroke in an Endemic Region
Authors: Stanley Zimba; Laura Benjamin
Year: 2022

Implementation of a Teleneurology Clinic in Zambia during the COVID‐19 Pandemic
Authors: Melody Asukile; Lorraine Chishimba; Mashina Chomba; Moses Mataa; Frighton Mutete; Naluca Mwendaweli; Kunda Yumbe; Stanley Zimba; Gloria Habanyama; Sydney Shampile et al.
Year: 2022

Inpatient Management of Acute Stroke of Unknown Type in Resource-Limited Settings
Authors: Morgan L. Prust; Deanna Saylor; Stanley Zimba; Fred Stephen Sarfo; Gentle S. Shrestha; Aaron Berkowitz; Nirali Vora
Year: 2022

Clinical Reasoning: An Unusual Case of Acute Psychosis and Tetraparesis in a Young Zambian Man
Authors: Stanley Zimba; Lorraine Chishimba; Mashina Chomba; Deanna Saylor
Year: 2021

Immune reconstitution inflammatory syndrome: a report of TB-IRIS after switching from efavirenz to dolutegravir
Authors: Stanley Zimba; Nyuma Mbewe; Lorraine Chishimba; Mashina Chomba; Deanna Saylor
Year: 2021

Conclusion

Dr. Zimba’s contributions exemplify the qualities of a transformative clinician–scientist who bridges research, practice, and leadership. His work has significantly advanced the understanding and treatment of neurological disorders in Zambia, while also elevating medical education and training standards. Through his leadership positions, he has shaped healthcare policy, specialist training, and advocacy for neurological health. Looking to the future, his research and leadership promise to strengthen neurology as a field in Africa, leaving a legacy of scientific advancement, patient-centered care, and mentorship for future generations.

Reza Amani | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Reza Amani | Clinical Neuroscience | Best Researcher Award

Prof. Reza Amani | Isfahan University of Medical Sciences | Iran

Dr. Reza Amani is a distinguished academic and clinical nutritionist whose career has been dedicated to advancing the science of human nutrition and dietetics. His early academic training in nutrition science laid a solid foundation for his extensive research and clinical work in chronic disease management, functional foods, and weight management therapies. He has held key academic and leadership positions, contributed prolifically to scholarly literature, and engaged in international teaching and research collaborations. His expertise has also been recognized through fellowships, visiting professorships, and advisory roles in national health and food policy.

Profile

Google Scholar

Early Academic Pursuits

Dr. Reza Amani began his academic journey in the field of nutrition science with a deep commitment to understanding the relationship between diet and health. His early studies in nutrition provided a strong scientific foundation, which he further expanded through advanced degrees in nutrition science. His doctoral research refined his expertise in applied human nutrition and clinical dietetics, laying the groundwork for his future contributions to both academia and clinical practice. These formative years were crucial in shaping his lifelong dedication to advancing knowledge in clinical nutrition and diet therapy.

Professional Endeavors

Over the course of his career, Dr. Amani has held influential academic and leadership positions in leading medical universities, where he has contributed to teaching, mentoring, and program development. His professional endeavors extend beyond academia, with significant roles in nutrition consultation, policy advising, and collaboration with the food industry. Through his service as a head of departments and research centers, he has demonstrated effective leadership in advancing institutional goals while nurturing an environment of academic excellence.

Contributions and Research Focus

Dr. Amani’s scholarly contributions center on clinical nutrition, dietetics, and the therapeutic applications of functional foods. His research has particularly emphasized medical nutrition therapy in chronic diseases, antioxidant-rich diets, and weight management approaches. Through a combination of clinical practice and research, he has explored innovative nutritional solutions and therapeutic diets that address modern health challenges. His body of work reflects a dedication to bridging science and practice, ensuring that research findings translate into effective interventions for public health and patient care.

Academic Publications and Knowledge Dissemination

A prolific scholar, Dr. Amani has authored an extensive collection of scientific papers and academic books in the field of nutrition and dietetics. His publications have enriched the scientific community with insights into functional food formulations, nutritional interventions for chronic disease management, and applied strategies in weight reduction. Beyond publishing, he has actively engaged in organizing and managing academic workshops, seminars, and webinars, ensuring the dissemination of cutting-edge knowledge to a wider audience of professionals, students, and practitioners.

Accolades and Recognition

Dr. Amani’s expertise and commitment have been recognized both nationally and internationally. He has been invited as a visiting scholar and professor at esteemed universities abroad, reflecting his international standing in the field of nutrition science. His fellowship training in clinical nutrition, with a particular focus on obesity management, further underscores his professional recognition and global engagement. His long-term membership in national boards and advisory positions within health ministries and industry demonstrates the trust placed in his expertise at the highest levels of nutrition governance.

Impact and Influence

The impact of Dr. Amani’s work extends across multiple domains, from shaping academic curricula and research priorities to influencing national nutrition policies and guiding food industries. His consultancy roles with health sectors and large industries highlight his ability to apply academic insights to real-world contexts. Moreover, his clinical nutrition practice and ownership of diet therapy clinics serve as a model of integrating academic knowledge with direct patient care. By advancing both scientific knowledge and practical solutions, he has influenced a generation of students, colleagues, and policymakers.

Legacy and Future Contributions

Dr. Amani’s legacy lies in his sustained contributions to clinical nutrition research, his leadership in academic institutions, and his role in shaping health strategies through nutritional science. As a mentor, author, and consultant, he has created pathways for future advancements in functional food research and chronic disease management. Looking forward, his future contributions are expected to continue bridging global collaborations, fostering innovative dietary solutions, and training the next generation of nutrition scientists who will carry forward his vision of integrating scientific research with human health advancement.

Publications

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … – M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, … – 2024

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … – M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, … – 2024

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 – JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, … – 2024

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 – SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, … – 2024

Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 – VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, … – 2024

Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial – N Sharifi, R Amani, E Hajiani, B Cheraghian – 2014

Shiftworking, nutrition and obesity: implications for workforce health-a systematic review – R Amani, T Gill – 2013

Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: association with digestive symptoms and quality of life – R Choghakhori, A Abbasnezhad, A Hasanvand, R Amani – 2017

Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … – RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, … – 2024

Correlation between dietary zinc intakes and its serum levels with depression scales in young female students – R Amani, S Saeidi, Z Nazari, S Nematpour – 2010

Conclusion

Dr. Amani’s career reflects a remarkable combination of academic scholarship, clinical expertise, and leadership in nutrition science. His contributions have not only advanced research in functional foods and medical nutrition therapy but have also translated into practical health solutions for chronic disease management and weight control. With a legacy of over a hundred publications, leadership in research centers, and consultancy roles at the national level, he stands as a leading figure in the field. Moving forward, his work is set to inspire new generations of nutrition scientists and further strengthen global collaborations in advancing human health through nutrition.

Gulcin Gacar | Neurodegenerative Disease | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Gulcin Gacar | Neurodegenerative Disease | Best Researcher Award

Prof. Dr. Gulcin Gacar | Kocaeli University | Turkey

Associate Professor Dr. Gulcin Gacar of Kocaeli University is a distinguished researcher and educator in the fields of stem cell biology, regenerative medicine, and clinical microbiology. With over 200 scientific publications, including 54 in Web of Science and 37 in Scopus, she has garnered more than 900 citations and achieved an h-index of 17. Her groundbreaking research focuses on mesenchymal stem cells and exosomes, particularly their applications in neurodegenerative diseases like Alzheimer’s. She leads nationally funded projects and serves as a mentor to graduate students, contributing significantly to Turkey’s scientific advancement in cellular and molecular therapy.

Academic Profile

Google Scholar
Orcid

Early Academic Pursuits

From the outset of her academic journey, Dr. Gülçin Gacar exhibited a strong dedication to medical sciences, particularly clinical microbiology and regenerative medicine. Her foundational studies laid the groundwork for her specialization in stem cell biology and advanced biomedical techniques. As she advanced through the academic ranks, her commitment to translational research became evident, inspiring a deep dive into the dynamic world of mesenchymal stem cells and cellular therapies.

Professional Endeavors

Currently serving as an Associate Professor at Kocaeli University, Dr. Gacar is affiliated with the Center for Stem Cell and Gene Therapies under the Institute of Health Sciences. She plays a critical role in bridging theoretical knowledge with clinical application. Her professional journey is characterized by a robust combination of teaching, research, and leadership, where she supervises graduate-level research and oversees important institutional initiatives in stem cell-based innovation.

Contributions and Research Focus

Dr. Gacar’s research primarily revolves around mesenchymal stem cells, exosomes (extracellular vesicles), and advanced applications of stem cell biology. One of her key projects involves investigating the therapeutic potential of exosomes derived from adipose tissue-origin mesenchymal stem cells on Alzheimer’s disease models using human neuroblastoma SHSY5Y cells. This cutting-edge study, supported by national scientific funding, illustrates her focus on neurological disorders and cellular therapies. With over 200 academic publications, including 54 indexed in Web of Science and 37 in Scopus, her work has become a cornerstone in regenerative medicine and neurocellular research.

Accolades and Recognition

Dr. Gacar’s exceptional scholarship is reflected in her impressive citation record—garnering over 900 citations with an h-index of 16 on Web of Science and 17 on Scopus. These metrics not only underscore the academic relevance of her research but also highlight her influence in the global scientific community. Her contributions have positioned her as a key opinion leader and trusted consultant in TÜBİTAK-funded national projects, further validating her expertise and dedication to scientific excellence.

Impact and Influence

Beyond publications and projects, Dr. Gacar is actively involved in mentoring the next generation of scientists. She has supervised numerous graduate theses, fostering a research culture grounded in innovation, rigor, and ethical science. Her influence extends into policy-making and practical clinical research, making her a vital figure in the implementation of stem cell technologies in both experimental and therapeutic contexts.

Legacy and Future Contributions

Dr. Gacar continues to expand the frontiers of stem cell research and regenerative neuroscience. Her ongoing efforts in developing novel diagnostic and therapeutic modalities through cellular and molecular engineering are poised to transform clinical approaches to degenerative diseases. With each project and publication, she reinforces her commitment to scientific discovery and paves the way for future breakthroughs in biotechnology and personalized medicine.

Neuroscience and Regenerative Innovation

At the intersection of neuroscience and regenerative biology, Dr. Gacar’s work exemplifies the possibilities of interdisciplinary research. Her current focus on exosome-based therapies in neurodegenerative conditions represents a bold step into the future of non-invasive, cell-free therapeutics. As the landscape of neuroscience evolves, her pioneering work will undoubtedly contribute to novel clinical strategies and global scientific advancement.

Publication

Isolation and in vitro characterisation of dental pulp stem cells from natal teeth
E Karaöz, BN Doğan, A Aksoy, G Gacar, S Akyüz, S Ayhan, ZS Genç
2010

Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers
E Karaoz, A Aksoy, S Ayhan, AE Sarıboyacı, F Kaymaz, M Kasap
2009

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum
K Schallmoser, E Rohde, A Reinisch, C Bartmann, D Thaler, C Drexler, …
2008

High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple …
H Vahaboglu, F Budak, M Kasap, G Gacar, S Torol, A Karadenizli, …
2006

Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems
PC Demircan, AE Sariboyaci, ZS Unal, G Gacar, C Subasi, E Karaoz
2011

Protective effects of resveratrol on aging-induced cognitive impairment in rats
SS Gocmez, N Gacar, T Utkan, G Gacar, PJ Scarpace, N Tumer
2016

The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets
AT Özdemir, RBÖ Özdemir, C Kırmaz, AE Sarıboyacı, ZSÜ Halbutoğlları, …
2016

PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.
F Kolayli, G Gacar, A Karadenizli, A Sanic, H Vahaboglu, Study Group
2005

Phenotypic and proteomic characteristics of human dental pulp derived mesenchymal stem cells from a natal, an exfoliated deciduous, and an impacted third molar tooth
G Akpinar, M Kasap, A Aksoy, G Duruksu, G Gacar, E Karaoz
2014

The role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells
YM Lee, SY Shin, SS Jue, IK Kwon, EH Cho, ES Cho, SH Park, EC Kim
2014

Conclusion 

Considering her scholarly output, impactful research on stem cell-based therapies, leadership in national research initiatives, and dedication to mentoring, Dr. Gulcin Gacar is highly deserving of the Best Researcher Award. Her innovative work in exosome-based treatment strategies for neurodegenerative diseases positions her as a leader in translational medical science. With continued emphasis on global engagement and high-impact dissemination, her research will not only advance scientific frontiers but also contribute meaningfully to patient care and public health. Thus, she stands as an exemplary model of academic excellence, innovation, and social relevance in biomedical sciences.

Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Dr. Antonella Santuccione Chadha, Women` s Brain Foundation,  Switzerland.

Dr. Antonella Chadha Santuccione is a highly accomplished clinical pathologist, neuroscientist, and executive leader with notable expertise in clinical trial management and cognitive behavioral therapy. Born in Italy and based in Switzerland, she has held executive roles and board memberships across biotech and healthcare organizations. She is also the founder and pro-bono CEO of the Women’s Brain Foundation, emphasizing her commitment to neuroscience and gender-specific brain health.

Profile

Scopus
Orcid

📚 Early Academic Pursuits

Dr. Antonella Chadha Santuccione’s academic foundation is deeply rooted in medical science and behavioral therapy, reflecting her passion for understanding the human mind and body. Born on June 13, 1974, in Penne, Italy, she pursued her education in medicine, earning her MD with specialization in Clinical Pathology. Furthering her academic rigor, she attained credentials from FMH and MEBEKO and completed a CAS in Clinical Trial Management. With an eye toward holistic care and human psychology, she expanded her studies to include Cognitive Behavioral Therapy. Her diverse training laid the groundwork for a multifaceted approach to clinical neuroscience, bridging biology, diagnostics, and therapeutic psychology.

🧪 Professional Endeavors

Throughout her professional journey, Dr. Santuccione has combined her clinical acumen with entrepreneurial vision. After relocating to Switzerland, she took on advisory roles in several neuro-focused start-ups including Bottneuro, Altoida, Pipra, ReconnectLab, and EqualCare, where she played a pivotal role in aligning scientific discovery with patient-centered innovation. Serving as an Executive Director and Board Member across multiple initiatives, she brought together cross-disciplinary teams to push the frontiers of diagnostics and digital health. Her pro-bono leadership as the Founder and CEO of the Women’s Brain Foundation further demonstrates her commitment to addressing gender disparities in brain health research and care.

🧠 Contributions and Research Focus

Dr. Santuccione’s work focuses on the intersection of neuroscience, gender-specific medicine, and clinical innovation. Her research advocacy highlights the importance of considering sex differences in neurodegenerative diseases such as Alzheimer’s, a field historically underexplored. By promoting personalized approaches to brain health, she has helped shape how researchers and clinicians think about prevention, diagnosis, and treatment across genders. Her insights into cognitive decline, early diagnostic markers, and patient-centric treatment frameworks have influenced both academic thought and clinical practice. Additionally, her work in start-ups integrates AI and data-driven technologies to monitor cognitive health, marking her as a forerunner in digital neuroscience.

🏅 Accolades and Recognition

Dr. Santuccione’s contributions have earned her widespread acclaim both within Switzerland and internationally. She was selected among the Top 100 Business Women in Switzerland from 2018 to 2023, a testament to her sustained influence in science and innovation. In 2019, she was named Woman of the Year by Women in Business CH through a public election, highlighting her societal impact beyond the scientific community. The World Sustainability Award in 2020 and the Bold Women Award Switzerland in 2022 recognized her efforts in building ethical, inclusive scientific models. Most recently, she received the Empowering Women Award 2024 and was featured among the Women to Watch 2025, celebrating her as a role model for future leaders.

🌍 Impact and Influence

Beyond her clinical and scientific achievements, Dr. Santuccione has become a global advocate for change in the healthcare landscape. Her work challenges the traditional silos of medicine, psychology, and technology, offering integrative solutions that are ethical and inclusive. She has empowered countless women in STEM through her foundation, speaking engagements, and mentorship programs. Her influence extends into public policy discussions and public health awareness campaigns, where she brings attention to the need for gender equity and individualized treatment in brain disorders. She is not only a scientist but a communicator who bridges science and society.

💡 Legacy and Future Contributions

Dr. Antonella Chadha Santuccione is a trailblazer shaping the next era of neuroscience through compassion-driven research and visionary leadership. Her legacy lies in her determination to dismantle systemic barriers in medicine—especially those that affect women—and in creating frameworks where innovation serves the individual. With ongoing roles in biotech leadership, nonprofit work, and public advocacy, she is set to further influence global conversations around brain health, mental wellness, and gendered research. Her career is a beacon for aspiring researchers who believe that science should serve humanity with empathy, precision, and equity.

🧬 A Champion for Brain Science and Humanity

Dr. Santuccione embodies the rare synthesis of scientific brilliance, leadership excellence, and humanitarian vision. Her work underscores a commitment to better understanding the human brain—not only through the lens of pathology, but also through the lens of experience, gender, and empathy. As she continues her journey, she stands as a symbol of what it means to be a 21st-century neuroscientist: grounded in evidence, driven by innovation, and devoted to people.

Publication

1. Title: Women’s brain health and brain capital
Authors: Laura Castro-Aldrete, Megan Greenfield, Erin Smith, Harris A. Eyre, Mariapaola Barbato, Lucy Pérez, Antonella Santuccione Chadha
Year: 2025

2. Title: Abortion and Miscarriage on Twitter: Sentiment and Polarity Analysis from a gendered perspective
Authors: Olivier Philippe, María Flores Rodero, Claire Yohalem Furtick, Laura Planas Simón, Maria Teresa Ferretti, Antonella Santuccione Chadha, Laia Subirats Maté, Davide Cirillo, María José Rementeria
Year: 2024

3. Title: Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
Authors: Matamoros-Angles A, Mohammadi B, Song F, Shafiq M, Brenna S, Puig B, Glatzel M, Altmeppen HC
Year: 2023

4. Title: Global synergistic actions to improve brain health for human development
Authors: Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, et al.
Year: 2023

5. Title: Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Authors: Laura Castro-Aldrete, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Antonella Santuccione Chadha
Year: 2023

6. Title: Towards AI-driven longevity research: An overview
Authors: Marino N, Putignano G, Cappilli S, Chersoni E, Antonella Santuccione Chadha, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B
Year: 2023

7. Title: Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Authors: Pfundstein G, Nikonenko AG, Sytnyk V
Year: 2022

8. Title: Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus
Authors: Ojeda-Juárez D, Lawrence JA, Soldau K, Pizzo DP, Wheeler E, Aguilar-Calvo P, Khuu H, Chen J, Malik A, Funk G, et al.
Year: 2022

9. Title: Digital biomarkers and sex impacts in Alzheimer’s disease management – potential utility for innovative 3P medicine approach
Authors: Harms RL, Ferrari A, Meier IB, Martinkova J, Santus E, Marino N, Cirillo D, Mellino S, Catuara Solarz S, Tarnanas I, et al.
Year: 2022

🏁 Conclusion

Dr. Antonella Chadha Santuccione’s career is a model of interdisciplinary excellence, innovation, and advocacy. Her ability to blend neuroscience research with executive leadership and public engagement sets her apart as a visionary in brain health. She not only advances the scientific understanding of neurodegeneration but also actively reshapes how gender and equity are addressed in medical research. With a lasting legacy in both scientific and humanitarian domains, she is exceptionally well-suited for high-level recognition such as the Best Researcher Award and remains a powerful voice shaping the future of neuroscience globally.

 

Jørgen Slots | Clinical Neuroscience |

Published on by Neuroscientists

Prof. Dr. Jørgen Slots | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jørgen Slots, University of Southern California,  United States.

Dr. Jørgen Slots is an internationally recognized scholar in periodontology and oral microbiology, with a rich academic and professional background rooted in Denmark, the United States, and Sweden. After completing multiple advanced degrees—including a D.D.S., Ph.D., D.M.D., and M.B.A.—he held tenured and leadership roles at esteemed institutions such as the Royal Dental College, SUNYAB, and the University of Göteborg. His research focused on microbial causes of periodontal disease, bridging the gap between laboratory science and clinical treatment. Throughout his career, he has been a pioneer in integrating microbiology into dental education and has significantly influenced both teaching and clinical standards globally. His work continues to inform practices in oral health and inspire the next generation of researchers and clinicians.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born in 1944 in Vejle, Denmark, Dr. Jørgen Slots embarked on a lifelong journey in dentistry and biomedical science that began at the prestigious Royal Dental College in Copenhagen. He earned his D.D.S. in 1969 and continued to delve deeper into academic excellence with an M.S. (Lic. Odont.) in 1974. His passion for periodontology led him to complete postgraduate education in this specialty by 1976, setting the stage for a research-intensive career. Not stopping there, he pursued advanced studies in microbiology at the Forsyth Dental Center in Boston, Massachusetts, where he earned a Certificate in Microbiology in 1977. By 1979, he had completed his doctoral thesis (Dr. Odont./Ph.D.), a reflection of his rigorous scientific training and commitment to academic inquiry.

🧪 Professional Endeavors in Dental Science

Dr. Slots’ career spans both private practice and academia, beginning with clinical work in Copenhagen from 1969 to 1976. However, his true calling was in academia and research, where he quickly rose through the ranks at the Royal Dental College, becoming a tenured associate professor in the Department of Periodontology and Bacteriology. His academic influence extended internationally as he moved to the United States, joining the State University of New York at Buffalo (SUNYAB) as a visiting associate professor in 1977. His multifaceted roles there included teaching, research, and graduate mentorship. In 1982, his expertise was recognized with a professorial and chair appointment at the University of Göteborg in Sweden, where he led the Department of Oral Microbiology until 1986.

🔬 Contributions and Research Focus

Dr. Slots’ core research has focused on periodontal microbiology, particularly the microbial etiology of periodontal diseases and the role of anaerobic bacteria in oral infections. His extensive background in both clinical periodontology and microbiology enabled him to bridge these disciplines, pioneering investigations into microbial pathogenesis, host responses, and antimicrobial therapy. His work at the intersection of dentistry and microbiology has contributed significantly to the understanding of how bacterial biofilms influence periodontal health and disease progression. Through his positions in leading institutions, he has mentored countless students and young researchers in translational oral biology.

🏅 Accolades and Recognition

Throughout his distinguished career, Dr. Slots has earned numerous accolades that acknowledge both his scholarly achievements and teaching excellence. His academic journey includes obtaining a D.M.D. from the University of Pennsylvania in 1986, further consolidating his clinical credentials. In 1989, he expanded his skillset by earning an M.B.A. from the Wharton School, indicating his interest in healthcare administration and leadership. Such accomplishments reflect a rare blend of scientific acumen, clinical expertise, and administrative insight that is seldom seen in one individual. His tenured appointments and leadership roles speak volumes about the respect he commands in his field.

🌍 Impact and Global Influence

Dr. Slots’ contributions have had global implications, influencing not only North American dental education but also shaping European periodontal research. His tenure at institutions in Denmark, Sweden, and the United States illustrates his international standing and thought leadership. By combining laboratory science with clinical application, he has contributed to international standards in oral hygiene practices, periodontal disease diagnostics, and treatment protocols. His collaborative work across continents has helped create a robust, evidence-based approach to periodontal care that is taught and practiced worldwide.

📚 Legacy in Dental Education and Microbiology

As a graduate faculty member and department chair, Dr. Slots played a vital role in curriculum development, graduate training, and interdisciplinary integration of oral microbiology into mainstream dental education. He has influenced a generation of oral biologists and periodontists who continue to build upon his foundational work. His teaching style, grounded in research and clinical relevance, made him a beloved educator and mentor. The ripple effects of his academic stewardship can still be seen in the progressive research and pedagogical models employed at the University of Southern California and other leading dental institutions.

🔭 Future Vision and Continuing Relevance

Though his primary academic career has matured, the legacy of Dr. Slots remains very much alive in ongoing research studies, collaborative clinical trials, and academic dialogues. His integration of clinical practice with microbiological research stands as a model for future dental scientists aiming to address emerging challenges in oral-systemic health. With a unique blend of intellectual rigor and compassionate mentorship, Dr. Slots has laid a foundation that will support future breakthroughs in both academic and applied dental sciences. His life’s work continues to inspire innovation and scientific inquiry in oral health worldwide.

Publication

Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions
A Ashimoto, C Chen, I Bakker, J Slots – 1996

Subgingival microflora and periodontal disease
J Slots – 1979

Periodontitis: facts, fallacies and the future
J Slots – 2017

Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival
J Slots, RJ Genco – 1984

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases
J Slots, MA Listgarten – 1988

Selective medium for isolation of Actinobacillus actinomycetemcomitans
J Slots – 1982

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: a Cross-Sectional Microbiological Investigation
J Slots, HS Reynolds, RJ Genco – 1980

Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases
ILC Chapple, R Genco, Working Group 2 of the Joint EFP/AAP Workshop – 2013

The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults
J Slots, L Bragd, M Wikström, G Dahlén – 1986

Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment
J Slots, M Ting – 1999

Antibiotics in periodontal therapy: advantages and disadvantages
J Slots, TE Rams – 1990

The predominant cultivable microflora of advanced periodontitis
J Slots – 1977

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: Prevalence in Patient Groups and Distribution of Biotypes and Serotypes Within Families
JJ Zambon, LA Christersson, J Slots – 1983

Systemic antibiotic therapy in periodontics
AJV Winkelhoff, TE Rams, J Slots – 1996

Microbial differences in 2 clinically distinct types of failures of osseointegrated implants
ES Rosenberg, JP Torosian, J Slots – 1991

The predominant cultivable organisms in juvenile periodontitis
J Slots – 1976

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
J Slots, BG Rosling – 1983

Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy
J Slots, P Mashimo, MJ Levine, RJ Genco – 1979

Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
JJ Zambon, J Slots, RJ Genco – 1983

🏁 Conclusion

Dr. Jørgen Slots’ career stands as a remarkable example of interdisciplinary excellence in dental science. Through his research in periodontal microbiology, leadership in academic institutions, and dedication to global dental education, he has left a lasting legacy. His contributions have not only advanced scientific knowledge but also improved clinical approaches to oral healthcare worldwide. Dr. Slots remains a towering figure whose impact resonates in the fields of periodontology, microbiology, and beyond.

Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki,  Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

 

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

 

  • Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Thyroid Disease and Systemic Lupus Erythematosus
    Author(s): [Not specified]
    Year: 2023

 

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Dr. Katherine Mandeville, University of California San Diego, United States.

Dr. Katherine Mandeville is a distinguished pediatric emergency physician and academician whose career reflects a commitment to excellence in both clinical care and research. With a strong academic foundation in biochemistry and medicine from the University of New Mexico, she pursued advanced clinical training at leading institutions such as the University of Colorado and Phoenix Children’s Hospital. Her academic and clinical trajectory has led her to a prominent role at the University of California, San Diego (UCSD), where she serves as an Associate Clinical Professor in the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital.

Profile

Scopus
Orcid

 

🎓 Early Academic Pursuits

Dr. Katherine Mandeville’s journey into the medical field was rooted in a solid foundation in science and critical inquiry. She began her academic path studying biochemistry and chemical engineering at the University of New Mexico, where she also explored non-degree coursework at Albuquerque Technical Vocational Institute. Her early academic versatility revealed a strong analytical mindset and a deep interest in human health and systems. In 1999, she earned her Medical Degree from the University of New Mexico School of Medicine, setting the stage for a career centered on both patient care and research-driven excellence.

🩺 Professional Endeavors

Following her graduation from medical school, Dr. Mandeville pursued intensive clinical training at the University of Colorado Health Sciences Center, where she completed her pediatric internship, residency, and advanced to a fellowship in Pediatric Emergency Medicine at Phoenix Children’s Hospital. These formative experiences immersed her in the fast-paced, high-stakes environment of emergency pediatrics. Since joining the University of California, San Diego (UCSD), she has progressed from Associate to Assistant and now Associate Clinical Professor within the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital. Her clinical role complements her academic responsibilities, fostering a dual commitment to exceptional care and education.

🔬 Contributions and Research Focus

Dr. Mandeville’s research trajectory is marked by a keen interest in bridging clinical care and evidence-based medicine. Her decision to pursue a Master of Science in Clinical Research at the University of New Mexico’s Health Sciences Center demonstrates a deliberate move toward translational science and healthcare innovation. Her work integrates real-world clinical challenges in pediatric emergency departments with scientific inquiry, focusing on improving outcomes for vulnerable pediatric populations. While her biography does not specify individual research projects or publications, her advanced training and consistent academic appointments suggest active involvement in research development, collaborative studies, or clinical protocols aimed at advancing pediatric emergency medicine.

🏆 Accolades and Recognition

Dr. Mandeville’s credentials reflect longstanding recognition in the field of pediatrics. She is certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Emergency Medicine—a rare and prestigious combination. Her sustained licensure in California and prior credentials in Nevada highlight her clinical credibility, while her affiliation with institutions such as UCSD and Rady Children’s Hospital place her in nationally ranked centers of pediatric care. The progression of her academic titles further underscores institutional trust in her leadership, mentorship, and research capabilities.

🌍 Impact and Influence

Throughout her career, Dr. Mandeville has consistently served at the intersection of medicine, mentorship, and systemic impact. At Rady Children’s Hospital—a major referral center in Southern California—she has influenced both the quality of emergency pediatric care and the professional development of young physicians. Her expertise and clinical judgment are undoubtedly shaping the training experiences of future pediatricians, residents, and fellows. Moreover, her presence in a teaching hospital and research-driven university ensures that her influence extends beyond clinical settings into broader academic and public health circles.

🔗 Legacy and Future Contributions

Dr. Mandeville is well-positioned to leave a lasting legacy in pediatric emergency care and clinical education. With her strong academic background, research training, and high-level clinical experience, she represents the next generation of clinician-researchers dedicated to evidence-based improvements in pediatric health. Her ongoing work at UCSD is likely to contribute to innovations in emergency care delivery, interdisciplinary teaching, and policy development in children’s health services. As medical systems increasingly prioritize translational research and quality improvement, her dual role as educator and researcher will only grow more pivotal.

🧪 Commitment to Research-Driven Medicine

What sets Dr. Mandeville apart is her integration of research training into her clinical identity. The MSCR program she completed reflects a structured and methodical approach to data analysis, study design, and outcomes research—skills that are vital in transforming bedside observations into peer-reviewed evidence. While not all research is visible in public citations, her long-term affiliation with academic medical centers and role in an evidence-based specialty suggests a strong alignment with research objectives. Her career embodies the principle that the best medical care is informed by rigorous scientific investigation, continuous learning, and collaborative innovation.

Publication

  • Title: Effects of Timing to Diagnosis and Appendectomy in Pediatric Appendicitis
    Author(s): Mandeville K, Monuteaux M, Pottker T, Bulloch B
    Year: 2015

 

  • Title: The Frequency of Postreduction Interventions After Successful Enema Reduction of Intussusception
    Author(s): Lessenich EM, Kimia AA, Mandeville K, Li J, Landschaft A, Tsai A, Bachur R
    Year: 2015

 

  • Title: Intussusception: Clinical Presentations and Imaging Characteristics
    Author(s): Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B
    Year: 2012

 

  • Title: Management of the Child After Enema-Reduced Intussusception: Hospital or Home?
    Author(s): Chien M, Willyerd FA, Mandeville K, Hostetler MA, Bulloch B
    Year: 2012

 

  • Title: Using Appendicitis Scores in the Pediatric ED
    Author(s): Mandeville K, Pottker T, Bulloch B, Liu J
    Year: 2010

 

  • Title: Brain Oxygen Utilization Is Unchanged by Hypoglycemia in Normal Humans: Lactate, Alanine, and Leucine Uptake Are Not Sufficient to Offset Energy Deficit
    Author(s): Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ
    Year: 2005

 

  • Title: Presentation, Evaluation, and Outcomes of Infants Under Three Months With Skull Fractures
    Author(s): Mandeville K
    Year: Not specified (date not provided in source)

 

🏁 Conclusion

Dr. Katherine Mandeville exemplifies the role of a clinician-researcher in modern medicine. Her robust educational background, commitment to pediatric emergency care, and pursuit of research-driven solutions have positioned her as a valuable leader in her field. Her influence spans clinical innovation, academic mentorship, and systemic healthcare improvements, making her a key contributor to both pediatric patient outcomes and medical education. As she continues her work at UCSD and Rady Children’s Hospital, her legacy is poised to grow through impactful research, mentorship, and advocacy for best practices in pediatric emergency medicine.

Daon Hwang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang,  Depatment of Physical Therapy, Korea Natiional University of Transportation,  South Korea.

Daon Hwang is a dedicated physical therapist and Ph.D. candidate at Korea National University of Transportation, with a strong academic and clinical foundation in adult neurological rehabilitation. His research portfolio includes six completed projects and six peer-reviewed publications, focusing on stroke rehabilitation, gait analysis, neurorehabilitation, and assistive device development. With a practical background in clinical therapy and consulting experience in device usability, he effectively bridges the gap between research and real-world application. His active involvement in professional organizations further enriches his contributions to the rehabilitation field.

Profile

Orcid

🎓 Early Academic Pursuits

Daon Hwang began his academic journey with a deep interest in the human body and its recovery mechanisms, leading him to pursue a career in physical therapy. He earned both his Bachelor’s and Master’s degrees in Physical Therapy from Korea National University of Transportation (KNUT). His early academic years were marked by diligence and a curiosity-driven approach to the complexities of neurological rehabilitation. His strong academic performance and growing passion for evidence-based practice set the stage for his current doctoral research.

💼 Professional Endeavors

As a licensed physical therapist, Daon Hwang has accumulated meaningful clinical experience, particularly in the field of adult neurological rehabilitation. His hands-on work with stroke patients has fueled his commitment to integrating practical therapy with innovative research. His current role as a Ph.D. candidate at KNUT allows him to bridge clinical practice with academic exploration, where he also provides consultancy on assistive devices. Daon continues to evolve both as a practitioner and as a scholar in the rehabilitation sciences.

🧠 Contributions and Research Focus

Daon’s primary research focuses include stroke rehabilitation, neurorehabilitation, gait analysis, and the development of assistive technologies. He has successfully completed six research projects, exploring diverse aspects such as proprioceptive training and the usability of rehabilitation devices. His scholarly output includes six peer-reviewed journal publications—two in SCI-indexed journals and four in KCI-indexed journals. These works contribute to enhancing therapeutic protocols and improving patients’ functional outcomes, particularly in post-stroke recovery.

🧪 Research Innovation and Impact

Daon’s innovative contributions are evident in his work with assistive device usability, having collaborated on three industry consulting projects to improve device design and user experience for stroke patients. His research has not only advanced academic knowledge but also offered real-world applicability in clinical settings. His studies often highlight the integration of biomechanical analysis and rehabilitation techniques to create more personalized and effective interventions.

🏅 Accolades and Professional Involvement

While Daon Hwang has not yet published books or acquired patents, his membership in several esteemed professional bodies reflects his dedication to continued learning and contribution to the field. He is an active member of the Korean Academy of Orthopedic Manipulative Physical Therapy, the Korean Physical Therapy Association, and the Korea Proprioceptive Neuromuscular Facilitation Association. Through these affiliations, he stays at the forefront of developments in physical therapy and rehabilitation science.

🌍 Influence and Collaboration

Though he has not formally reported collaborative research projects, Daon’s consulting work and clinical partnerships demonstrate a growing sphere of influence. His findings are increasingly referenced by peers and practitioners, particularly in the areas of gait mechanics and neuro-motor rehabilitation. His dual role in academia and practice ensures his research remains grounded in clinical relevance.

🔮 Legacy and Future Contributions

Looking ahead, Daon Hwang aspires to further integrate technology with neurorehabilitation strategies, aiming to develop more efficient, adaptive tools for stroke survivors. His doctoral work and future post-doctoral goals center on refining rehabilitative methods through data-driven research and interdisciplinary collaboration. With a vision of contributing meaningfully to global rehabilitation science, Daon is poised to leave a lasting legacy of innovation, empathy, and excellence in physical therapy.

Publication

  • Title: Usability Test for an Over-Ground Walking Assistance Robotic Device Based on the Mecanum Wheel
    Authors: Daon Hwang; EunPyeong Choi; Ki Hun Cho
    Year: 2025

 

  • Title: Changes in Balance Ability, Physical Performance and Lower Extremity Proprioception according to the Compression Stockings in University Students
    Authors: Daon Hwang; Hyeong Gyu Kim; Na Young Kang; Eun Seo Park; Hyun Young Yoo; Jun Young Lee; Seo Yeong Jang; Cheol Woo Hwang; Ki Hun Cho
    Year: 2025

 

  • Title: Usability Test for a Cane-Combined Weight Support Feedback Device
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2024

 

  • Title: Usability Test for Motion Tracking Gait Assistive Walker
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2023

 

  • Title: The Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke: A Pilot Study
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

  • Title: Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

✅ Conclusion

Driven by a passion for enhancing recovery outcomes in stroke patients, Daon Hwang has positioned himself as a promising scholar and practitioner in the field of physical therapy. His blend of academic rigor, clinical expertise, and innovation in assistive technologies reflects a career marked by meaningful impact and ongoing growth. As he advances toward completing his Ph.D., his work continues to shape the future of neurorehabilitation—promoting evidence-based practices and contributing to patient-centered healthcare innovations.